Reflect on the provided data and tweets to anticipate if the closing price of $amgn is going to increase or decrease at 2017-05-31. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-16,-0.1,0.3,-0.3,0.0,0.0,-0.3,0.6,0.9,0.8,0.8,0.9
2017-05-17,1.1,1.4,-0.1,-1.8,-1.8,1.2,2.1,2.5,2.6,2.6,2.6
2017-05-18,-0.4,0.5,-1.1,0.6,0.6,0.5,1.2,1.7,1.9,1.9,2.0
2017-05-19,0.7,1.3,-0.1,-0.9,-0.9,1.1,1.8,2.4,2.8,2.7,2.8
2017-05-22,0.4,1.0,-0.4,-2.2,-2.2,2.5,3.5,4.4,4.8,4.8,4.9
2017-05-23,-0.9,0.3,-1.2,0.7,0.7,1.1,2.3,3.3,3.8,4.0,4.1
2017-05-24,0.1,0.3,-0.5,0.3,0.3,0.4,1.6,2.6,3.2,3.5,3.6
2017-05-25,-0.2,0.4,-0.5,0.5,0.5,-0.5,0.9,1.8,2.4,2.8,2.9
2017-05-26,0.4,0.7,-0.1,-0.3,-0.3,-0.4,0.9,1.7,2.5,3.0,3.0
2017-05-30,0.8,1.0,-0.2,-0.7,-0.7,0.5,1.2,2.1,3.0,3.5,3.6

2017-05-16: $chrs $mnta $amgn etc¡ªuspto action¡ª&gt;bullish4 *all* companies seeking 2commercialize humira fobs for us mkt:¡­ |rt AT_USER $abbv $amgn $chrs ipr of humira 135 patent invalidated in ipr; big win fo
2017-05-17: $amgn: amgen highlights data to be presented at asco; oral presentation of new analysis on limited renal toxicity... | my thoughts on why most broke people think stock chatrooms are a 'scam' ! $fb $tw
2017-05-18: rt AT_USER 7 areas to watch from the asco abstracts  $incy $amgn $kite $juno $rhhby $lly $pfe $nvs $mrk $azn|amgen $amgn trading at 120% of 52-week low. worth a look? $bmy $lly $abbv $pfe  |#asco2017 
2017-05-19: manifest millennial snowflake malaise &amp; instant gratification materializes after $amgn tenders legitimate justification 4 $arwr past/future|rt AT_USER AT_USER yes little $nwbo presenting aside $am
2017-05-20: commented on 3 things in biotech you should learn today: may 20, 2017  $amgn $mrk $nvs $rhhbf $rhhby|$amgn max pain is 157.50 for maturity 05/26/2017. prev close = 156.51.   |$kite $juno $celg $ziop $
2017-05-21: rt AT_USER $amgn amgen¡¯s ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this|rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn'
2017-05-22: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy|$amgn enbrel good into the 2028-29 timeframe, so no such perverse incentive to keep s
2017-05-23: these 3 biotech stocks have ballooned, AT_USER #stocks $pfe, $jnj, $sny, $amgn, $gern, $regn, $ibb, $ptla |rt AT_USER $nwbo tapping on .16 breach of that should see good run #asco17 $amgn $pfe |rt AT_
2017-05-24: $amgn: more insider selling today, no position in the stock.|rt AT_USER $rdus abaloparatide advantages  as compared to teriparatide and $amgn romosozumab in #osteoporosis |$amgn - statement of changes
2017-05-25: since then $amgn #fail - |$amgn the bull pattern is confirmed &amp; a buy signal is issued @  buy level: 155.3500   target: 163.1175|investors sell amgen, inc. $amgn on strength on insider selling |in
2017-05-26: $amgn high open interest range is 150.00 to 165.00 for option expiration 06/02/2017.  |rt AT_USER therapy focus - as cgrp race hots up the only headache could be paying for them  $lly $amgn $nvs $¡­|f
2017-05-27: 3 things in biotech you should learn today: may 27, 2017  $amgn $kite $mrk $pfe|rt AT_USER $spx company insider trades in past 5 days. $wmt $aapl $csco $ice $regn $sre $intu $efx $msft $luv $udr $dhr 
2017-05-28: $amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 highest call.  |safety signal derails expected approval of $amgn bone drug |rt AT_USER #asco2017 is right around the corner. here's what to
2017-05-29: {new video} biotech analysis + trade ideas: $ibb $celg $gild $myl $amgn $agn --&gt;  |more information about $amgn on  #diis #iamnetwork |$amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 h
2017-05-30: #amgen sues the fda over marketing exclusivity for sensipar in pediatric patients. read more:  $amgn|interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|amgen 
Answer:
Reflect on the provided data and tweets to anticipate if the closing price of $amgn is going to increase or decrease at 2017-05-31. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-16,-0.1,0.3,-0.3,0.0,0.0,-0.3,0.6,0.9,0.8,0.8,0.9
2017-05-17,1.1,1.4,-0.1,-1.8,-1.8,1.2,2.1,2.5,2.6,2.6,2.6
2017-05-18,-0.4,0.5,-1.1,0.6,0.6,0.5,1.2,1.7,1.9,1.9,2.0
2017-05-19,0.7,1.3,-0.1,-0.9,-0.9,1.1,1.8,2.4,2.8,2.7,2.8
2017-05-22,0.4,1.0,-0.4,-2.2,-2.2,2.5,3.5,4.4,4.8,4.8,4.9
2017-05-23,-0.9,0.3,-1.2,0.7,0.7,1.1,2.3,3.3,3.8,4.0,4.1
2017-05-24,0.1,0.3,-0.5,0.3,0.3,0.4,1.6,2.6,3.2,3.5,3.6
2017-05-25,-0.2,0.4,-0.5,0.5,0.5,-0.5,0.9,1.8,2.4,2.8,2.9
2017-05-26,0.4,0.7,-0.1,-0.3,-0.3,-0.4,0.9,1.7,2.5,3.0,3.0
2017-05-30,0.8,1.0,-0.2,-0.7,-0.7,0.5,1.2,2.1,3.0,3.5,3.6

2017-05-16: $chrs $mnta $amgn etc¡ªuspto action¡ª&gt;bullish4 *all* companies seeking 2commercialize humira fobs for us mkt:¡­ |rt AT_USER $abbv $amgn $chrs ipr of humira 135 patent invalidated in ipr; big win fo
2017-05-17: $amgn: amgen highlights data to be presented at asco; oral presentation of new analysis on limited renal toxicity... | my thoughts on why most broke people think stock chatrooms are a 'scam' ! $fb $tw
2017-05-18: rt AT_USER 7 areas to watch from the asco abstracts  $incy $amgn $kite $juno $rhhby $lly $pfe $nvs $mrk $azn|amgen $amgn trading at 120% of 52-week low. worth a look? $bmy $lly $abbv $pfe  |#asco2017 
2017-05-19: manifest millennial snowflake malaise &amp; instant gratification materializes after $amgn tenders legitimate justification 4 $arwr past/future|rt AT_USER AT_USER yes little $nwbo presenting aside $am
2017-05-20: commented on 3 things in biotech you should learn today: may 20, 2017  $amgn $mrk $nvs $rhhbf $rhhby|$amgn max pain is 157.50 for maturity 05/26/2017. prev close = 156.51.   |$kite $juno $celg $ziop $
2017-05-21: rt AT_USER $amgn amgen¡¯s ph 3 news tonite is bad, estimates were for $800m+ or so, stock should be down $3-$5 on this|rt AT_USER $amgn sees cardiovascular safety signal in romo arch trial- now doesn'
2017-05-22: $aapl $amat $amgn $amtd $amzn $atvi trade long and short positions from the #nasdaq, up to 1500% since 2010.  $spy|$amgn enbrel good into the 2028-29 timeframe, so no such perverse incentive to keep s
2017-05-23: these 3 biotech stocks have ballooned, AT_USER #stocks $pfe, $jnj, $sny, $amgn, $gern, $regn, $ibb, $ptla |rt AT_USER $nwbo tapping on .16 breach of that should see good run #asco17 $amgn $pfe |rt AT_
2017-05-24: $amgn: more insider selling today, no position in the stock.|rt AT_USER $rdus abaloparatide advantages  as compared to teriparatide and $amgn romosozumab in #osteoporosis |$amgn - statement of changes
2017-05-25: since then $amgn #fail - |$amgn the bull pattern is confirmed &amp; a buy signal is issued @  buy level: 155.3500   target: 163.1175|investors sell amgen, inc. $amgn on strength on insider selling |in
2017-05-26: $amgn high open interest range is 150.00 to 165.00 for option expiration 06/02/2017.  |rt AT_USER therapy focus - as cgrp race hots up the only headache could be paying for them  $lly $amgn $nvs $¡­|f
2017-05-27: 3 things in biotech you should learn today: may 27, 2017  $amgn $kite $mrk $pfe|rt AT_USER $spx company insider trades in past 5 days. $wmt $aapl $csco $ice $regn $sre $intu $efx $msft $luv $udr $dhr 
2017-05-28: $amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 highest call.  |safety signal derails expected approval of $amgn bone drug |rt AT_USER #asco2017 is right around the corner. here's what to
2017-05-29: {new video} biotech analysis + trade ideas: $ibb $celg $gild $myl $amgn $agn --&gt;  |more information about $amgn on  #diis #iamnetwork |$amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 h
2017-05-30: #amgen sues the fda over marketing exclusivity for sensipar in pediatric patients. read more:  $amgn|interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|amgen 
Answer:+Rise